
Costco Wholesale Corporation is testing whether its membership trust can travel into Medicare. The retailer and nonprofit SCAN Group plan jointly branded Medicare Advantage and supplement products, pending regulatory approval. The first three markets contain about 5 million Medicare-eligible people.
| Measure | Value | From $947.74 |
|---|---|---|
| Consensus | Buy | 39 analysts |
| Average target | $1,077 | +13.7% |
| Low target | $740 | -21.9% |
| High target | $1,315 | +38.8% |
Medicare adds commission potential, store visits and another retention touchpoint. Strong sales and renewal rates fund the experiment.
Rules bar membership bundling. Weak conversion or delayed approval would leave investors paying roughly 46 times forward earnings for the core story alone.
The market needs numbers before treating Medicare as a material earnings driver.
THURSDAY
Walmart's U.S. comparable-sales miss raised concern about consumer trade-offs. Costco fell 2.45% on the group's busiest session.
FRIDAY
Buyers reclaimed about $6.3 billion of estimated value. The bounce did not erase the week's 1.39% decline.
Costco's 6.9% adjusted U.S. July comp remains well above Walmart's latest 2.6% quarterly pace. The stock's premium rests on that consistency.
Risk: expensive shares leave little room for slower traffic or renewals. Fuel inflation also pressures shoppers and freight.
| View | Target | Upside / downside |
|---|---|---|
| Bernstein · Buy | $1,194 | +27.1% |
| Consensus · Buy | $1,077 | +14.6% |
| RBC · Sector Perform | $1,000 | +6.4% |
| Roth · Sell | $781 | −16.9% |